Netweb Technologies India Limited (NETWEB)
General Updates
Investor Presentation - Q2FY27
- H1 FY27 Revenue from Operations ₹21,430 Mn; Operating EBITDA ₹3,230 Mn (15.1% margin); PAT ₹2,220 Mn (10.3% margin)
- ROCE at 38.6% and ROE at 31.4% in H1 FY27
- Strong order book of ₹26,290 Mn with pipeline of ₹111,518 Mn and L1 bids of ₹6,525 Mn
- Early mover in High-end Computing Solutions with focus on AI systems, private cloud, HPC
- Strategy emphasizes innovation, chip-agnostic design, and sovereign AI infrastructure
- Manufacturing facility in Faridabad with 128 R&D engineers and 18 patents
- Diverse marquee customer base with repeat customers contributing 94.4% revenue in H1 FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NETWEB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NETWEB to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Netweb Technologies India Limited
Important.
The summary above is generated automatically from Netweb Technologies India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.